Annual Current Assets
$105.71 M
-$67.04 M-38.81%
December 31, 2023
Summary
- As of February 8, 2025, BOLT annual total current assets is $105.71 million, with the most recent change of -$67.04 million (-38.81%) on December 31, 2023.
- During the last 3 years, BOLT annual current assets has risen by +$80.35 million (+316.81%).
- BOLT annual current assets is now -44.12% below its all-time high of $189.16 million, reached on December 31, 2021.
Performance
BOLT Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$57.15 M
-$19.48 M-25.43%
September 30, 2024
Summary
- As of February 8, 2025, BOLT quarterly total current assets is $57.15 million, with the most recent change of -$19.48 million (-25.43%) on September 30, 2024.
- Over the past year, BOLT quarterly current assets has dropped by -$19.48 million (-25.43%).
- BOLT quarterly current assets is now -78.93% below its all-time high of $271.21 million, reached on March 31, 2021.
Performance
BOLT Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
BOLT Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.8% | -25.4% |
| 3 y3 years | +316.8% | -25.4% |
| 5 y5 years | +649.7% | -25.4% |
BOLT Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.1% | at low | -70.9% | at low |
| 5 y | 5-year | -44.1% | +316.8% | -78.9% | +125.3% |
| alltime | all time | -44.1% | +649.7% | -78.9% | +125.3% |
Bolt Biotherapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $57.15 M(-25.4%) |
| Jun 2024 | - | $76.63 M(-19.4%) |
| Mar 2024 | - | $95.06 M(-10.1%) |
| Dec 2023 | $54.08 M(-1.8%) | $105.71 M(-15.7%) |
| Sep 2023 | - | $125.47 M(-4.0%) |
| Jun 2023 | - | $130.67 M(-0.7%) |
| Mar 2023 | - | $131.61 M(-23.8%) |
| Dec 2022 | $55.06 M | $172.75 M(-1.2%) |
| Sep 2022 | - | $174.83 M(-3.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $181.26 M(-7.6%) |
| Mar 2022 | - | $196.09 M(+3.7%) |
| Dec 2021 | $118.56 M(+459.7%) | $189.16 M(-15.0%) |
| Sep 2021 | - | $222.49 M(-10.3%) |
| Jun 2021 | - | $248.15 M(-8.5%) |
| Mar 2021 | - | $271.21 M(+969.4%) |
| Dec 2020 | $21.18 M(+68.8%) | $25.36 M(-36.1%) |
| Sep 2020 | - | $39.68 M(+10.5%) |
| Dec 2019 | $12.55 M(+569.2%) | $35.90 M |
| Dec 2018 | $1.88 M | - |
FAQ
- What is Bolt Biotherapeutics annual total current assets?
- What is the all time high annual current assets for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics annual current assets year-on-year change?
- What is Bolt Biotherapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics quarterly current assets year-on-year change?
What is Bolt Biotherapeutics annual total current assets?
The current annual current assets of BOLT is $105.71 M
What is the all time high annual current assets for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high annual total current assets is $189.16 M
What is Bolt Biotherapeutics annual current assets year-on-year change?
Over the past year, BOLT annual total current assets has changed by -$67.04 M (-38.81%)
What is Bolt Biotherapeutics quarterly total current assets?
The current quarterly current assets of BOLT is $57.15 M
What is the all time high quarterly current assets for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high quarterly total current assets is $271.21 M
What is Bolt Biotherapeutics quarterly current assets year-on-year change?
Over the past year, BOLT quarterly total current assets has changed by -$19.48 M (-25.43%)